Back
Prime Medicine Vs. Larimar Therapeutics Industry Stock Comparison
Sell
20
PRME
Prime Medicine
Last Price:
3.92
Seasonality Move:
-25.18%
Sell
38
LRMR
Larimar Therapeutics
Last Price:
7.15
Seasonality Move:
-2.11%
Sell
20
Prime Medicine (PRME)
is a Sell
Is Prime Medicine a Buy, Sell or Hold?
- The current Prime Medicine [PRME] share price is $3.98. The Score for PRME is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- PRME is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
38
Larimar Therapeutics (LRMR)
is a Sell
Is Larimar Therapeutics a Buy, Sell or Hold?
- The current Larimar Therapeutics [LRMR] share price is $6.85. The Score for LRMR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- LRMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRME Stock Price Chart
What is Prime Medicine's stock price today?
-
The Prime Medicine share price today is $3.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRME is experiencing selling pressure, which indicates risk of future bearish movement.
LRMR Stock Price Chart
What is Larimar Therapeutics's stock price today?
-
The Larimar Therapeutics share price today is $6.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing slight buying pressure.
PRME Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 44.84 | Sell |
| Chaikin Money Flow: | -428485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.85 - 4.37) | Sell |
| Bollinger Bands (100): | (4.34 - 6.58) | Sell |
LRMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 40.95 | Sell |
| Chaikin Money Flow: | 35975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.18 - 8.16) | Sell |
| Bollinger Bands (100): | (7.14 - 9.08) | Sell |
PRME Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.95 | Buy |
| 20-day SMA: | 4.06 | Sell |
| 50-day SMA: | 4.7 | Sell |
| 200-day SMA: | 6.43 | Sell |
| 8-day EMA: | 3.96 | Buy |
| 20-day EMA: | 4.09 | Sell |
| 50-day EMA: | 4.59 | Sell |
| 200-day EMA: | 6.57 | Sell |
LRMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.21 | Sell |
| 20-day SMA: | 7.65 | Sell |
| 50-day SMA: | 8.27 | Sell |
| 200-day SMA: | 7.5 | Sell |
| 8-day EMA: | 7.16 | Sell |
| 20-day EMA: | 7.52 | Sell |
| 50-day EMA: | 7.88 | Sell |
| 200-day EMA: | 7.31 | Sell |
Prime Medicine Earnings Growth & PRME Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.13 per share, an increase this year of $0.17 per share, and an increase next year of $0.21 per share.
Larimar Therapeutics Earnings Growth & LRMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.69 per share, and a decrease next year of $0.43 per share.
Prime Medicine Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Larimar Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||